Credit Suisse’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$140K Sell
58,431
-262,070
-82% -$626K ﹤0.01% 2914
2023
Q4
$1.07M Sell
320,501
-44,005
-12% -$147K ﹤0.01% 2289
2023
Q3
$1.36M Sell
364,506
-17,851
-5% -$66.8K ﹤0.01% 2070
2023
Q2
$1.63M Sell
382,357
-27,911
-7% -$119K ﹤0.01% 2054
2023
Q1
$2.81M Sell
410,268
-28,256
-6% -$193K ﹤0.01% 1657
2022
Q4
$3.47M Sell
438,524
-35,087
-7% -$278K ﹤0.01% 1533
2022
Q3
$4.55M Buy
473,611
+220,374
+87% +$2.12M 0.01% 1298
2022
Q2
$1.83M Buy
253,237
+40,563
+19% +$294K ﹤0.01% 1967
2022
Q1
$2.74M Buy
212,674
+8,740
+4% +$113K ﹤0.01% 1850
2021
Q4
$3.25M Sell
203,934
-158,580
-44% -$2.53M ﹤0.01% 1806
2021
Q3
$5.83M Buy
362,514
+168,621
+87% +$2.71M ﹤0.01% 1432
2021
Q2
$2.68M Sell
193,893
-46,909
-19% -$649K ﹤0.01% 1982
2021
Q1
$3.52M Sell
240,802
-23,168
-9% -$338K ﹤0.01% 1768
2020
Q4
$4.59M Buy
263,970
+11,130
+4% +$193K ﹤0.01% 1582
2020
Q3
$4.64M Sell
252,840
-55,828
-18% -$1.02M ﹤0.01% 1334
2020
Q2
$5.51M Buy
308,668
+133,939
+77% +$2.39M ﹤0.01% 1254
2020
Q1
$2.83M Sell
174,729
-108,438
-38% -$1.76M ﹤0.01% 1465
2019
Q4
$5.1M Sell
283,167
-101,690
-26% -$1.83M ﹤0.01% 1404
2019
Q3
$7.8M Buy
384,857
+246,898
+179% +$5M 0.01% 1100
2019
Q2
$3.05M Sell
137,959
-44,795
-25% -$990K ﹤0.01% 1667
2019
Q1
$2.49M Sell
182,754
-5,376
-3% -$73.4K ﹤0.01% 1759
2018
Q4
$1.7M Sell
188,130
-1,562
-0.8% -$14.1K ﹤0.01% 1908
2018
Q3
$3.13M Sell
189,692
-29,559
-13% -$488K ﹤0.01% 1655
2018
Q2
$3.07M Buy
219,251
+71,691
+49% +$1M ﹤0.01% 1765
2018
Q1
$1.63M Buy
147,560
+35,856
+32% +$396K ﹤0.01% 2214
2017
Q4
$982K Sell
111,704
-30,778
-22% -$271K ﹤0.01% 2545
2017
Q3
$1.9M Sell
142,482
-7,270
-5% -$97K ﹤0.01% 2170
2017
Q2
$2.15M Sell
149,752
-14,361
-9% -$206K ﹤0.01% 1854
2017
Q1
$3.47M Buy
164,113
+21,958
+15% +$465K ﹤0.01% 1636
2016
Q4
$4M Sell
142,155
-30,084
-17% -$847K ﹤0.01% 1575
2016
Q3
$4.61M Buy
172,239
+133,249
+342% +$3.57M ﹤0.01% 1499
2016
Q2
$659K Buy
38,990
+11,090
+40% +$187K ﹤0.01% 2961
2016
Q1
$592K Sell
27,900
-6,029
-18% -$128K ﹤0.01% 2836
2015
Q4
$780K Buy
+33,929
New +$780K ﹤0.01% 2815
2015
Q3
Sell
-9,821
Closed -$284K 4036
2015
Q2
$284K Buy
+9,821
New +$284K ﹤0.01% 3757